1-15 of 15
Bernard Escudier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Editor's Note: ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy

Yosra Messai, Muhammad Zaeem Noman, Meriem Hasmim, Bassam Janji, Andrés Tittarelli, Marie Boutet, Véronique Baud, Elodie Viry, Katy Billot, Arash Nanbakhsh, Thouraya Ben Safta, Catherine Richon, Sophie Ferlicot, Emmanuel Donnadieu, Sophie Couve, Betty Gardie, Florence Orlanducci, Laurence Albiges, Jerome Thiery, Daniel Olive, Bernard Escudier, Salem Chouaib
Journal: Cancer Research
Cancer Res (2022) 82 (8): 1671.
https://doi.org/10.1158/0008-5472.CAN-22-0500
Published: 15 April 2022
View article titled, Editor's Note: ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy
Open the PDF for Editor's Note: ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy in another window
Journal Articles

Abstract CT188: IMmotion151: updated overall survival (OS) and exploratory analysis of the association of gene expression and clinical outcomes with atezolizumab plus bevacizumab vs sunitinib in patients with locally advanced or metastatic renal cell carcinoma (mRCC)

Brian I. Rini, Michael B. Atkins, Bernard Escudier, Thomas Powles, David F. McDermott, Boris Y. Alekseev, Jae-Lyun Lee, Daniil Stroyakovskiy, Cristina Suarez Rodriguez, Ugo De Giorgi, Frede Donskov, Begoña Mellado, Romain Banchereau, Habib Hamidi, Omara Khan, Veronica Craine, Mahrukh Huseni, Nick Flinn, Sarita Dubey, Robert Motzer
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT188.
https://doi.org/10.1158/1538-7445.AM2021-CT188
Published: 01 July 2021
View article titled, Abstract CT188: IMmotion151: updated overall survival (OS) and exploratory analysis of the association of gene expression and clinical outcomes with atezolizumab plus bevacizumab vs sunitinib in patients with locally advanced or metastatic renal cell carcinoma (mRCC)
Journal Articles

Abstract 1771: Phase 3 trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: exploratory molecular analysis of tumor biomarkers

Daniel J. George, Jean-Francois Martini, Yen-Hwa Chang, Michael Staehler, Jan Breza, Jean-Jacques Patard, Robert J. Motzer, Ahmed Magheli, Bernard Escudier, Giacomo Carteni, Paola Gerletti, Sherry Li, Michelle Casey, Brigitte Laguerre, Hardev S. Pandha, Allan J. Pantuck, Anup Patel, Maria Lechuga, Alain Ravaud
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 1771.
https://doi.org/10.1158/1538-7445.AM2017-1771
Published: 01 July 2017
View article titled, Abstract 1771: Phase 3 trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: exploratory molecular analysis of tumor biomarkers
Journal Articles

Abstract CT006: Crizotinib achieves objective responses and long-lasting disease control in patients (pts) with metastatic papillary renal cell carcinoma type 1 (PRCC1) with somatic MET mutations. EORTC phase II trial 90101 “CREATE”

Patrick Schoffski, Agnieszka Wozniak, Bernard Escudier, Piotr Rutkowski, Alan Anthoney, Sebastian Bauer, Jozef Sufliarsky, Carla van Herpen, Lars Lindner, Viktor Grünwald, Branko Zakotnik, Evelyne Lerut, Sandrine Marréaud, Michela Lia, Tiana Raveloarivahy, Sandra Collette, Laurence Albiges
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): CT006.
https://doi.org/10.1158/1538-7445.AM2016-CT006
Published: 15 July 2016
View article titled, Abstract CT006: Crizotinib achieves objective responses and long-lasting disease control in patients (pts) with metastatic papillary renal cell carcinoma type 1 (PRCC1) with somatic <em>MET</em> mutations. EORTC phase II trial 90101 “CREATE”
Journal Articles

Abstract 1306: Biomarker results from a clinical trial of nivolumab in patients (pts) with metastatic renal cell carcinoma (mRCC) (CA209-009): Gene expression, serum profiling for immune markers, and multiplex tissue immunohistochemistry (IHC)

Toni K. Choueiri, Mayer N. Fishman, Bernard Escudier, Walter M. Stadler, Scott Chasalow, Petra Ross-Macdonald, Maria Jure-Kunkel, Mario Sznol, Jason S. Simon
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1306.
https://doi.org/10.1158/1538-7445.AM2015-1306
Published: 01 August 2015
View article titled, Abstract 1306: Biomarker results from a clinical trial of nivolumab in patients (pts) with metastatic renal cell carcinoma (mRCC) (CA209-009): Gene expression, serum profiling for immune markers, and multiplex tissue immunohistochemistry (IHC)
Journal Articles

ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy

Yosra Messai, Muhammad Zaeem Noman, Meriem Hasmim, Bassam Janji, Andrés Tittarelli, Marie Boutet, Véronique Baud, Elodie Viry, Katy Billot, Arash Nanbakhsh, Thouraya Ben Safta, Catherine Richon, Sophie Ferlicot, Emmanuel Donnadieu, Sophie Couve, Betty Gardie, Florence Orlanducci, Laurence Albiges, Jerome Thiery, Daniel Olive, Bernard Escudier, Salem Chouaib
Journal: Cancer Research
Cancer Res (2014) 74 (23): 6820–6832.
https://doi.org/10.1158/0008-5472.CAN-14-0303
Published: 30 November 2014
View article titled, ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy
Open the PDF for ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy in another window
Includes: Multimedia, Supplementary data
Journal Articles

Abstract 1377: Characterisation of mechanisms of resistance to sunitinib in a unique pre-clinical RCC model

Melissa Taylor, Amélie Barthélémy, Bernard Escudier, Françoise Farace
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 1377.
https://doi.org/10.1158/1538-7445.AM2012-1377
Published: 15 April 2012
View article titled, Abstract 1377: Characterisation of mechanisms of resistance to sunitinib in a unique pre-clinical RCC model
Journal Articles

Abstract 4127: Levels of circulating CD45dimCD34+VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with targeted therapies

Françoise Farace, Claire Cropet, Ellen Blanc, David Pérol, Sylvie Négrier, Bernard Escudier
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 4127.
https://doi.org/10.1158/1538-7445.AM2011-4127
Published: 15 April 2011
View article titled, Abstract 4127: Levels of circulating CD45dimCD34+VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with targeted therapies
Journal Articles

Abstract 372: Circulating endothelial progenitor cell levels predict survival benefit in metastatic renal cell cancer patients treated with antiangiogenic agents

Françoise Farace, Marine Gross - Goupil, Elodie Tournay, Melissa Taylor, Catherine Hill, Bernard Escudier
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 372.
https://doi.org/10.1158/1538-7445.AM10-372
Published: 15 April 2010
View article titled, Abstract 372: Circulating endothelial progenitor cell levels predict survival benefit in metastatic renal cell cancer patients treated with antiangiogenic agents
Journal Articles

Membrane-Bound Interleukin (IL)-15 on Renal Tumor Cells Rescues Natural Killer Cells from IL-2 Starvation-Induced Apoptosis

Sebastian Wittnebel, Sylvie Da Rocha, Julien Giron-Michel, Abdelali Jalil, Paule Opolon, Bernard Escudier, Pierre Validire, Krystel Khawam, Salem Chouaib, Bruno Azzarone, Anne Caignard
Journal: Cancer Research
Cancer Res (2007) 67 (12): 5594–5599.
https://doi.org/10.1158/0008-5472.CAN-06-4406
Published: 15 June 2007
View article titled, Membrane-Bound Interleukin (IL)-15 on Renal Tumor Cells Rescues Natural Killer Cells from IL-2 Starvation-Induced Apoptosis
Open the PDF for Membrane-Bound Interleukin (IL)-15 on Renal Tumor Cells Rescues Natural Killer Cells from IL-2 Starvation-Induced Apoptosis in another window
Journal Articles

Biomarkers associated with clinical outcomes in TARGETs, a Phase III single-agent, placebo-controlled study of sorafenib in advanced renal cell carcinoma

James Elting, Douglas Bigwood, Sheryl Brown-Shimer, Walter Pickett, Timothy Sarr, Sarah Heald, Brian Schwartz, Minghua Shan, Chetan Lathia, Bernard Escudier, Ronald Bukowski, Ian Taylor
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 683–684.
Published: 15 April 2006
View article titled, Biomarkers associated with clinical outcomes in TARGETs, a Phase III single-agent, placebo-controlled study of sorafenib in advanced renal cell carcinoma
Journal Articles

CD158 Receptor Controls Cytotoxic T-Lymphocyte Susceptibility to Tumor-Mediated Activation-Induced Cell Death by Interfering with Fas Signaling

Asma Gati, Nadia Guerra, Catherine Gaudin, Sylvie Da Rocha, Bernard Escudier, Yann Lécluse, Ali Bettaieb, Salem Chouaib, Anne Caignard
Journal: Cancer Research
Cancer Res (2003) 63 (21): 7475–7482.
Published: 11 November 2003
View article titled, CD158 Receptor Controls Cytotoxic T-Lymphocyte Susceptibility to Tumor-Mediated Activation-Induced Cell Death by Interfering with Fas Signaling
Open the PDF for CD158 Receptor Controls Cytotoxic T-Lymphocyte Susceptibility to Tumor-Mediated Activation-Induced Cell Death by Interfering with Fas Signaling in another window
Journal Articles

T-Cell Receptor Repertoire in Neuroblastoma Patients

Dominique Valteau, Véronique Scott, Guislaine Carcelain, Olivier Hartmann, Bernard Escudier, Thierry Hercend, Frédéric Triebel
Journal: Cancer Research
Cancer Res (1996) 56 (2): 362–369.
Published: 01 January 1996
View article titled, T-Cell Receptor Repertoire in Neuroblastoma Patients
Open the PDF for T-Cell Receptor Repertoire in Neuroblastoma Patients in another window
Journal Articles

In Vivo Local Expansion of Clonal T Cell Subpopulations in Renal Cell Carcinoma

Catherine Gaudin, Pierre-Yves Dietrich, Sylvie Robache, Maryvonne Guillard, Bernard Escudier, Marie-Josée Terrier Lacombe, Anil Kumar, Frédéric Triebel, Anne Caignard
Journal: Cancer Research
Cancer Res (1995) 55 (3): 685–690.
Published: 01 February 1995
View article titled, <em>In Vivo</em> Local Expansion of Clonal T Cell Subpopulations in Renal Cell Carcinoma
Open the PDF for <em>In Vivo</em> Local Expansion of Clonal T Cell Subpopulations in Renal Cell Carcinoma in another window
Journal Articles

Free Human Chorionic Gonadotropin β Subunit in Gonadal and Nongonadal Neoplasms

Isabelle Marcillac, Frédéric Troalen, Jean-Michel Bidart, Pascale Ghillani, Vincent Ribrag, Bernard Escudier, Benoit Malassagne, Jean-Pierre Droz, Catherine Lhommé, Philippe Rougier, Pierre Duvillard, Michel Prade, Pierre-Marie Lugagne, François Richard, Thierry Poynard, Claude Bohuon, Jack Wands, Dominique Bellet
Journal: Cancer Research
Cancer Res (1992) 52 (14): 3901–3907.
Published: 01 July 1992
View article titled, Free Human Chorionic Gonadotropin β Subunit in Gonadal and Nongonadal Neoplasms
Open the PDF for Free Human Chorionic Gonadotropin β Subunit in Gonadal and Nongonadal Neoplasms in another window